STAR

📊 Financial Position

📈 Upcoming Trigger (Very Important) Q4 FY26 results expected in May 2026 Market expectations: Revenue: ~₹1,150–₹1,250 crore Profit: ~₹50–₹80 crore 👉 Results + FY27 guidance will be major stock-moving event 📉 Recent Performance Q3 results were moderate: Revenue ~₹1,080 crore Profit relatively low (~₹30 crore) Shows: Stable business But profit growth still inconsistent 🌍 Business Highlights Operates in 100+ countries Focus areas: US generics market Africa & emerging markets Strategy includes: Expanding regulated markets Cost optimization 📊 Financial Position ✅ Debt reduction over time (positive sign) ✅ Strong ROE historically high ⚠️ Sales growth is moderate (not very strong) ⚠️ Promoter holding is relatively low and partially pledged